Daiichi Sankyo Competitors and Similar CompaniesClear all

Boehringer Ingelheim's competitors and similar companies include AstraZeneca.
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim International is a pharmaceutical company specializing in animal health, human pharma, and biopharmaceutical contract manufacturing.
AstraZeneca
AstraZeneca
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
Founding Date
Founding Date
1958
Founding Date
1999
Type
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Ingelheim am Rhein, DE HQ
Ouled Fayet, DZ
Munro, AR
Macquarie Park, AU
Wien, AT
Minsk, BY
Bruxelles, BE
see more
Locations
Cambridge, GB HQ
Alger, DZ
Buenos Aires, AR
Macquarie Park, AU
Macquarie Park, AU
North Ryde, AU
Wien, AT
see more
Employees
Employees
1,2338% increase
Employees
94,300

Financial

Revenue (est.)
Revenue (est.)
€12.7b (FY, 2023)
Revenue (est.)
$58.7b (FY, 2025)
Cost of goods
Cost of goods
€4b (FY, 2023)
Cost of goods
$4.9b (FY, 2025)
Gross profit
Gross profit
€8.7b (FY, 2023)
Gross profit
$54.2b (FY, 2025)
Net income
Net income
€5.8b (FY, 2023)
Net income
$10.2b (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

AstraZeneca
HQ
Cambridge, GB
Employees
94,300

AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.

View company